1571 - 1580 of 7877 Results
Title
Year
-
OPENTitle: Power and Sample Size for Longitudinal Models in R -- The longpower Package and Shiny AppJournal Name: The R JournalPublisher: The R FoundationVol: 14Issue #: 1Start Page: 264End Page: 282Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32614/rj-2022-022Best OA location URL: https://journal.r-project.org/articles/RJ-2022-022/RJ-2022-022.pdfCitation Count: 18
-
OPENTitle: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.75253Best OA location URL: https://doi.org/10.7554/elife.75253Citation Count: 30
-
RESTRICTEDTitle: A biological classification of Huntington's disease: the Integrated Staging SystemJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 7Start Page: 632End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00120-xBest OA location URL: https://discovery.ucl.ac.uk/10151755/1/21.08.12%20HD-ISS%20Manuscript%20final%20submitted.pdfCitation Count: 86
-
RESTRICTEDTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 89
-
RESTRICTEDTitle: An MDS Evidence‐Based Review on Treatments for Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1566End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29059Citation Count: 0
-
RESTRICTEDTitle: CD11b agonists offer a novel approach for treating lupus nephritisJournal Name: Translational ResearchPublisher: Elsevier BVVol: 245Issue #:Start Page: 41End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.trsl.2022.03.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167730Citation Count: 11
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
RESTRICTEDTitle: Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 169Issue #:Start Page: 105721End Page: 105721Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105721Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105721Citation Count: 6
-
OPENTitle: Diabetes and Neuroaxonal Damage in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1568End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29067Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29067Citation Count: 6
- Editor's Note2022